Recovery & Repair
BPC-157 / KPV / TB-500
A three-peptide compounded protocol combining repair signaling with anti-inflammatory tripeptide support.
- Physician reviewed
- 503A pharmacy compounded
- Patient-specific prescription
Formats & pricing
- combination vial — reconstituted injectable$270
Pricing reflects the compounded preparation and physician review. Final therapy and dosing are determined only after your intake is reviewed.
Overview
What is BPC-157 / KPV / TB-500?
This protocol adds KPV — an alpha-MSH-derived tripeptide studied for inflammatory modulation — to the BPC-157 and TB-500 pairing, and is generally considered when gut and inflammatory concerns accompany a recovery goal.
Mechanism
How it works
KPV has been investigated for its effect on inflammatory signaling in epithelial tissue, while BPC-157 and TB-500 research focuses on repair, angiogenesis, and cell migration.
Wellness support
Potential wellness support areas
These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.
- Explored where recovery and inflammatory symptoms overlap
- Discussed within gut-focused wellness protocols
- Potential support for soft tissue and joint comfort
- Consolidates three peptides into one preparation
Administration
Format & dosing
Typically a daily subcutaneous injection. Your physician may recommend a defined cycle followed by reassessment.
Labs & monitoring
Labs, testing & monitoring
Your physician determines the final testing requirements for BPC-157 / KPV / TB-500 after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
Bloodwork status
Recent Labs Recommended
Commonly reviewed at baseline
- CBC
- Comprehensive metabolic panel (CMP)
- hs-CRP
- Vitamin D
- Ferritin
Follow-up & monitoring
Inflammatory markers such as hs-CRP may be rechecked at 8 to 12 weeks when they were elevated at baseline.
Who may not be a candidate
- Pregnancy or nursing
- Active malignancy without oncology clearance
- Known hypersensitivity to the preparation
Medication interactions
Your physician reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.
Safety
Safety & considerations
Compounded medication, not an FDA-approved product. Not appropriate with active malignancy. Full medication and condition review required at intake.
Regulatory status: Compounded. Evidence level: Preclinical. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed physician after review of your history.
Related therapies
Recovery & Repair
BPC-157
Connective tissue repair, joint mobility, and gut healing support.
Provider Determines Testing
Recovery & Repair
TB-500
Systemic tissue repair, flexibility, and injury recovery support.
Provider Determines Testing
Recovery & Repair
BPC-157 / TB-500
Dual-action recovery stack for tissue repair and systemic healing.
Provider Determines Testing
Physician reviewed
Every protocol is approved by a licensed physician.
503A compounded
Prepared by licensed US compounding pharmacies.
Patient-specific Rx
Prescriptions are issued in your name only.
No membership
No concierge fee and no subscription to browse or begin.